Literature DB >> 27861213

What's New in Pediatric Medial Epicondyle Fractures?

Jennifer J Beck1,2, Richard E Bowen1,2, Mauricio Silva1,2.   

Abstract

BACKGROUND: Medial epicondyle fractures are predominantly seen in adolescent, male patients. Historically, nonoperative intervention was the mainstay of treatment. With increasing upper extremity demands of young athletes and reports of valgus instability after nonoperative treatment, there has been an increased interest in operative indications. Controversy regarding proper imaging and measurement of displacement complicates decision-making algorithms. Review of recent literature is required for improved decision making.
METHODS: We searched the PubMed database for all papers related to the treatment of medial epicondyle fractures in patients under 18 years of age published between January 1, 2005 and March 15, 2016. This resulted in 39 papers written in English for review. Papers were included based upon subject matter and contribution of new findings to literature. Review articles were excluded.
RESULTS: In total, 39 papers were reviewed and 30 were included in this review. Five classic manuscripts on medial epicondyle fractures in children provide appropriate historical and background information as needed.
CONCLUSIONS: Medial epicondyle fractures represent a variety of low and high-energy mechanisms, displacement, treatment options, and complications. This paper reviews recent literature on these topics. Controversy regarding imaging modality, displacement measurement accuracy, and surgical indications still exist. Long term, patient based, functional outcome studies of operative versus nonoperative treatment are needed to improve our treatment algorithms of this injury. Treatment algorithms should be individualized to each specific patient and fracture. LEVEL OF EVIDENCE: Level 5.

Entities:  

Mesh:

Year:  2018        PMID: 27861213     DOI: 10.1097/BPO.0000000000000902

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  7 in total

Review 1.  Common Upper Extremity Injuries in Pediatric Athletes.

Authors:  Rhonda A Watkins; Celina De Borja; Faustine Ramirez
Journal:  Curr Rev Musculoskelet Med       Date:  2022-08-01

2.  Use of Digital Tomosynthesis in Assessing Accurate Medial Epicondyle Fracture Displacement as Compared With Conventional Radiography and Computed Tomography.

Authors:  Kristin S Livingston; Emily A Edwards; Michael Griffin; John D MacKenzie; Matthew A Zapala
Journal:  J Pediatr Orthop       Date:  2021 Nov-Dec 01       Impact factor: 2.537

3.  Medial Epicondyle Fracture in Children and Its Association with Increased Carrying Angle.

Authors:  Changhoon Jeong; Sang-Uk Lee; Hyun Gyun Kim; Sun Young Joo
Journal:  Int J Clin Pract       Date:  2022-01-31       Impact factor: 3.149

4.  Long-Term Outcomes of Operatively Treated Medial Epicondyle Fractures in Pediatric and Adolescent Patients.

Authors:  Ronak M Patel; Yash Tarkunde; Lindley B Wall; Gregory Schimizzi; Charles A Goldfarb
Journal:  J Hand Surg Glob Online       Date:  2021-04-05

5.  Pediatric medial humeral epicondyle fracture in children: Are biodegradable pins with tension band absorbable sutures efficient?

Authors:  Tamás Kassai; Marcell Varga; Gergő Józsa
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

6.  No Difference in Return to Sport and Other Outcomes Between Operative and Nonoperative Treatment of Medial Epicondyle Fractures in Pediatric Upper-Extremity Athletes.

Authors:  Derek Paul Axibal; Patrick Carry; Anne Skelton; Stephanie Watson Mayer
Journal:  Clin J Sport Med       Date:  2020-11       Impact factor: 3.454

7.  Management of medial humeral epicondyle fractures in children: a structured review protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.

Authors:  Sara L Dorman; James A Shelton; Robert Allen Stevenson; Kenneth Linkman; Jamie Kirkham; Daniel C Perry
Journal:  Trials       Date:  2018-02-20       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.